About Rajavithi Hospital
โรงพยาบาลราชวิถี เป็นโรงพยาบาลรัฐบาล นับเป็นโรงพยาบาลศูนย์วิชาการที่ใหญ่ที่สุดแห่งหนึ่ง ของกรมการแพทย์ กระทรวงสาธารณสุข ปัจจุบันทำหน้าที่เป็นศูนย์แพทยศาสตรศึกษาชั้นคลินิกและสถาบันร่วมผลิตแพทย์ให้กับวิทยาลัยแพทยศาสตร์ มหาวิทยาลัยรังสิต
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at Rajavithi Hospital
During the past decade, Rajavithi Hospital conducted 72 clinical trials. In the 10-year time frame, 72 clinical trials started and 15 clinical trials were completed, i.e. on
average, 20.8% percent of trials that started reached the finish line to date. In the past 5 years, 45 clinical trials started and 5 clinical trials were completed. i.e. 11.1%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Rajavithi Hospital" #1 sponsor was "Rajavithi Hospital" with 47 trials, followed by "Hoffmann-La Roche" with 18 trials
sponsored, "Pfizer" with 3 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored and "Genentech, Inc."
with 2 trials sponsored. Other sponsors include 16 different institutions and
companies that sponsored additional 25 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Rajavithi Hospital"
#1 collaborator was "Rajavithi Biomolecular Research Center" with 3 trials as a collaborator, "Chulalongkorn University" with 2 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator, "Hoffmann-La Roche" with 2 trials as a collaborator and "Navitas Life Sciences GmbH" with 2 trials as a collaborator. Other collaborators include 14 different institutions and companies that were
collaborators in the rest 24 trials.
Clinical Trials Conditions at Rajavithi Hospital
According to Clinical.Site data, the most researched conditions in "Rajavithi Hospital" are
"Abnormal Uterine Bleeding" (2 trials), "Arthritis, Rheumatoid" (2 trials), "Cesarean Section" (2 trials), "Gastric Cancer" (2 trials) and "Gastroesophageal Junction Adenocarcinoma" (2 trials). Many other conditions were trialed in "Rajavithi Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Rajavithi Hospital
Most popular intervention types in "Rajavithi Hospital" are "Drug" (64 trials), "Procedure" (10 trials), "Other" (9 trials), "Device" (4 trials) and "Diagnostic Test" (3 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (15 trials), "Atezolizumab" (8 trials), "Paclitaxel" (7 trials), "Docetaxel" (4 trials) and "Giredestrant" (3 trials). Other intervention names were less common.
Clinical Trials Genders at Rajavithi Hospital
The vast majority of trials in "Rajavithi Hospital" are
63 trials for "All" genders, 29 trials for "Female" genders and 1 trials for "Male" genders.
Clinical Trials Status at Rajavithi Hospital
Currently, there are 30 active trials in "Rajavithi Hospital".
2 are not yet recruiting,
15 are recruiting,
12 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 51 completed trials in Rajavithi Hospital,
undefined suspended trials,
and 4 terminated clinical trials to date.
Out of the total trials that were conducted in Rajavithi Hospital, 1 "Phase 1"
clinical trials were conducted, 10 "Phase 2" clinical
trials and 36 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 7 trials, and there were
also 31 trials that are defined as “Not Applicable".
Departments of Rajavithi Hospital
Rajavithi Hospital has several departments that took part in Clinical trials: "Rajavithi Hospital; Ophthalmology Department" - 2 trials